GlassScriptPhysician profile
Pablo S Rodriguez
NPI 1609964105
$1,394.59
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,374 · 2020: $21.06.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $229.07 | 2019 | |
| Merck Sharp & Dohme LLC | $211.07 | 2019 | |
| Mallinckrodt Enterprises LLC | $183.86 | 2019 | |
| Insmed, INC. | $121.13 | 2019 | |
| Viiv Healthcare Company | $115.18 | 2019 | |
| Gilead Sciences, INC. | $114.32 | 2019 | |
| Ucb, INC. | $104.08 | 2019 | |
| Amgen INC. | $76.47 | 2019-2020 | |
| Allergan, INC. | $53.91 | 2019 | |
| Celgene Corporation | $45.56 | 2019 | |
| Janssen Biotech, INC. | $43.40 | 2019 | |
| Theratechnologies INC. | $31.50 | 2019 | |
| Horizon Therapeutics Plc | $23.90 | 2019 | |
| Siemens Medical Solutions USA, INC. | $15.76 | 2019 | |
| Bioventus LLC | $14.12 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $11.26 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pablo Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.